Life Expectancy and Healthcare Spending pe... in Papua New Guinea

Published 2026-10-09 · 24Peaks Research

Papua New Guinea's life expectancy at birth is estimated at roughly 65 to 66 years as of the latest available year, while total health spending sits at approximately 2 to 3 percent of GDP — one of the lowest health expenditure ratios in the Asia-Pacific region. That combination of modest longevity and very low health outlays places the country well behind Pacific peers such as Fiji and Samoa, and far behind high-income comparators. Life expectancy and healthcare spending per capita are closely tracked together because they help investors and analysts gauge a country's human capital quality, labour force durability, and long-term fiscal pressure.

What These Indicators Measure

Life expectancy at birth is the average number of years a newborn would live if current age-specific mortality rates stayed constant throughout its lifetime. It is not a prediction; it is a snapshot of mortality conditions in a given year. The World Bank, UN, and IMF all publish variants, and small methodological differences can shift the number by a year or two. Because it captures outcomes across the whole population, it is widely used as a summary measure of a country's health status.

Healthcare spending per capita measures total expenditure on health divided by population, expressed in current or constant international dollars. Total health expenditure includes government spending, private insurance, out-of-pocket payments, and external donor funding. Analysts often also look at health spending as a share of GDP, which shows how much of a country's economic output is devoted to health relative to its income level. For low-income and lower-middle-income countries, external financing can be a large share of the total, which matters for sustainability.

The two indicators belong to the same analytical family: health financing inputs on one side, health outcomes on the other. Neither alone tells the full story, which is why 24Peaks presents them together.

Why It Matters for Investors and Policymakers

For investors, these indicators feed into sovereign risk and long-term growth assessments. A population with shorter life expectancy and high communicable disease burden typically has lower productivity, a smaller effective labour force, and higher absenteeism. That affects everything from consumer demand projections to the returns on infrastructure with multi-decade horizons.

Health spending also signals fiscal capacity and priorities. When health spending is very low as a share of GDP, it usually means either limited government revenue, competing budget demands such as debt service or defence, or heavy reliance on donors. Each of these has different implications for sovereign creditworthiness.

For policymakers and development institutions, the relationship runs both ways. Higher spending does not automatically buy longer life — governance, education, sanitation, nutrition, and geography all matter. But extremely low spending levels are almost always associated with weak health outcomes.

There is also a data quality dimension. In Papua New Guinea, vital registration coverage is incomplete, so life expectancy estimates rely heavily on survey data and modelling. Investors should treat single-year figures as approximations and focus on multi-year trends.

Recent Trends and Regional Context

Across the Pacific Islands, health outcomes vary widely. Fiji and Samoa have generally recorded higher life expectancy than Papua New Guinea, in part because of smaller, more accessible populations and longer-established health systems. Melanesian neighbours Solomon Islands and Vanuatu show intermediate outcomes.

Papua New Guinea's trend over recent decades has been one of gradual improvement punctuated by setbacks. Life expectancy rose through the 2000s and 2010s but progress has been uneven, reflecting the country's difficult geography — rugged terrain, dispersed islands, and a large rural population with limited access to clinics. Communicable diseases including tuberculosis, malaria, and pneumonia remain significant causes of mortality, while non-communicable diseases such as diabetes and cardiovascular illness are rising.

Health spending as a share of GDP has hovered in the low single digits, well below the regional average for middle-income countries and below the levels recommended by global health bodies for universal health coverage. Per capita health spending in international dollar terms remains a fraction of what Fiji or Samoa spend, even after adjusting for purchasing power.

Donor financing, including from Australia and multilateral agencies, has historically funded a meaningful share of the health budget, particularly for disease-specific programmes. That creates a structural vulnerability: shifts in donor priorities can translate into real spending changes.

The COVID-19 period strained the system, disrupted routine services, and slowed progress on several health indicators. Recovery has been gradual, and the latest available data on 24Peaks reflects the most recent compiled series.

Comparison Examples

To put Papua New Guinea in context, it is useful to compare with countries at different income levels and in different regions.

Fiji, a Pacific peer with a similar-sized population but higher income per capita, has consistently recorded life expectancy in the upper 60s to around 70 years, with health spending as a share of GDP typically between 3 and 5 percent. Samoa is comparable or slightly higher on both measures. Indonesia, a large lower-middle-income neighbour, has life expectancy around 68 to 72 years and health spending of roughly 3 to 4 percent of GDP. Vietnam, another lower-middle-income comparator, has achieved life expectancy above 73 years with health spending in the mid-single digits as a share of GDP, illustrating that outcomes depend on efficiency and public health systems, not spending alone.

Values are approximate and drawn from publicly available World Bank, UN, and IMF methodology. 24Peaks hosts the latest compiled series for each country.

Limitations to Keep in Mind

First, life expectancy is an average and hides distribution. In Papua New Guinea, outcomes differ sharply between urban and rural areas, and between provinces. A national figure understates the gap between Port Moresby and remote highland or island communities.

Second, health spending data quality varies. Government budget figures, donor disbursements, and out-of-pocket spending are collected through different systems, and consolidation into a single "total health expenditure" number involves estimation. Comparisons across countries should be treated as indicative.

Third, correlation is not causation. Countries can achieve long life expectancy at low cost through strong public health measures, and countries can spend heavily with mediocre outcomes. Spending is an input, not an outcome.

Fourth, currency and purchasing power adjustments matter. Comparing per capita spending in nominal US dollars against GDP shares can produce very different rankings. Analysts should use consistent methodologies.

Fifth, revisions are common. Historical series for both indicators are periodically revised as new survey data or census results become available, so year-on-year comparisons should use the same vintage of data.

FAQ

What is Papua New Guinea's life expectancy at birth?

As of the latest available year, it is roughly 65 to 66 years, according to World Bank and UN estimates. Figures are modelled because civil registration coverage is incomplete. The most recent compiled series is available on 24Peaks.

How much does Papua New Guinea spend on healthcare?

Total health expenditure is approximately 2 to 3 percent of GDP, among the lowest in the Asia-Pacific region. Per capita spending is a small fraction of levels in Fiji or Samoa. Donor financing funds a significant share of the total.

Is healthcare spending in Papua New Guinea rising?

It has fluctuated rather than risen steadily as a share of GDP. Economic growth, budget priorities, and donor cycles all influence the level. The latest available data on 24Peaks shows the most recent compiled trend.

How does Papua New Guinea compare with Fiji and Samoa?

Papua New Guinea generally records lower life expectancy and lower health spending than both. Fiji and Samoa have better service access and higher per capita expenditure. The gaps reflect geography, income levels, and health system capacity.

Why do life expectancy and health spending matter for investors?

They are proxies for human capital quality and long-term fiscal pressure. Shorter life expectancy and weak health systems can reduce productivity and raise future social costs. Investors use them alongside GDP, debt, and demographic data in sovereign analysis.

Compare this indicator across countries and over time on the 24Peaks workbench.